Drug Adminstration Schedule
Showing 1 - 25 of >10,000
Health-risk Behaviours, Drug Abuse Trial in Hong Kong (Health-risk behaviors, Theory of planned behavior, Self-determination
Not yet recruiting
- Health-risk Behaviours
- Drug Abuse
- Health-risk behaviors
- +5 more
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Jun 26, 2023
Adherence Trial in Chicago (EHR + (Text or Portal))
Completed
- Adherence
- EHR + (Text or Portal)
-
Chicago, IllinoisNorthwestern University
Jan 3, 2022
Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy Trial in Toronto (Risperidone, Olanzapine)
Recruiting
- Schizophrenia and Related Disorders
- +3 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jul 20, 2022
COVID-19 Trial (Recommended treatment schedule, Usual care)
Not yet recruiting
- COVID-19
- Recommended treatment schedule
- Usual care
- (no location specified)
Nov 2, 2022
Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,
Completed
- Stable Angina
- +2 more
- 3-months DAPT
- 1-year DAPT
-
Busan, Korea, Republic of
- +11 more
Jan 8, 2023
COVID-19 Trial (Recommended treatment schedule, Usual care)
Not yet recruiting
- COVID-19
- Recommended treatment schedule
- Usual care
- (no location specified)
Feb 22, 2022
Cocaine Use Disorder, Contingency Management Trial in United States (prize contingency management on a traditional twice weekly
Completed
- Cocaine Use Disorder
- Contingency Management
- prize contingency management on a traditional twice weekly schedule for cocaine abstinence
- +2 more
-
Bridgeport, Connecticut
- +3 more
Jan 3, 2022
Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)
Active, not recruiting
- Advanced Cancer
- +16 more
-
Scottsdale, Arizona
- +3 more
Dec 22, 2022
HIV, Cryptosporidiosis Trial in Cape Town, Bangkok (Nitazoxanide)
Completed
- HIV Infections
- Cryptosporidiosis
-
Cape Town, South Africa
- +1 more
Oct 28, 2021
Opioid-Related Disorders, Substance-Related Disorders Trial in New Haven (Buprenorphine)
Completed
- Opioid-Related Disorders
- Substance-Related Disorders
-
New Haven, ConnecticutAPT Residential Services Division
Jul 3, 2020
Decompensated Cirrhosis Trial (Isomaltooligosaccharides (IMO))
Not yet recruiting
- Decompensated Cirrhosis
- Isomaltooligosaccharides (IMO)
- (no location specified)
Nov 12, 2023
Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)
Recruiting
- Locally Advanced Basal Cell Carcinoma
-
Brescia, ItalyAsst Degli Spedali Civili Di Brescia
Aug 3, 2022
Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)
Active, not recruiting
- Breast Cancer
- +3 more
- Palbociclib
- +7 more
-
Saint Louis, Missouri
- +1 more
Jul 20, 2022
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
HIV-1-infection Trial in Spain (Dolutegravir/Lamivudine as a single pill, Bictegravir/Emtricitabine/Tenofovir alfenamide as a
Recruiting
- HIV-1-infection
- Dolutegravir/Lamivudine as a single pill
- Bictegravir/Emtricitabine/Tenofovir alfenamide as a single pill.
-
Alcorcón, Madrid, Spain
- +28 more
Jun 20, 2022
Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)
Active, not recruiting
- Breast Cancer
- Capecitabine
- +2 more
-
Hartford, Connecticut
- +9 more
Apr 15, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)
Completed
- Gastrointestinal Stromal Tumors (GISTs)
- Imatinib Mesylate
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Prostate Cancer Trial in Tampa (Abiraterone Acetate)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 3, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)
Not yet recruiting
- Recurrent Ovarian Cancer
- +3 more
- RP-6306
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 25, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 5, 2022
Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jun 27, 2023